About Fabtech
Fabtech is a company based in Mumbai (India) founded in 2002 by Aasif Ahsan Khan. It operates as a Professional Services. Fabtech has raised $175.05 thousand across 1 funding round from investors including Acaciaa International TR LLC. Fabtech offers products and services including Start-to-Finish Solutions, Solutions for Air, Solutions for Water, and Solutions for Process. Fabtech operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
- Headquarter Mumbai, India
- Founders Aasif Ahsan Khan
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Fabtech Technologies Limited
-
Annual Revenue
$37.69 M (USD)43.74as on Mar 31, 2025
-
Net Profit
$5.44 M (USD)70.67as on Mar 31, 2025
-
EBITDA
$4.43 M (USD)9.93as on Mar 31, 2025
-
Total Equity Funding
$175.05 K (USD)
in 1 rounds
-
Latest Funding Round
$175.05 K (USD), Seed
Feb 28, 2012
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Fabtech
Fabtech is a publicly listed company on the NSE with ticker symbol FABTECH in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Fabtech
Fabtech offers a comprehensive portfolio of products and services, including Start-to-Finish Solutions, Solutions for Air, Solutions for Water, and Solutions for Process.
Complete turnkey solutions for pharmaceutical manufacturing are provided.
Air quality solutions for pharmaceutical facilities are offered.
Water treatment solutions for pharmaceutical processes are delivered.
Process optimization solutions for pharmaceutical production are provided.
People of Fabtech
Unlock access to complete
Funding Insights of Fabtech
Fabtech has successfully raised a total of $175.05K through 1 strategic funding round. The most recent funding activity was a Seed round of $175.05 thousand completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $175,048
-
First Round
First Round
(28 Feb 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2012 | Amount | Seed - Fabtech | Valuation | Acaciaa International TR LLC |
|
Investors in Fabtech
Fabtech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Acaciaa International TR LLC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fabtech
Financial Statements - Fabtech
Fabtech Comparisons
Competitors of Fabtech
Fabtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Suite solutions are provided for payers and healthcare providers.
|
|
| domain | founded_year | HQ Location |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| domain | founded_year | HQ Location |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| domain | founded_year | HQ Location |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| domain | founded_year | HQ Location |
Technology-based consultancy and product development services are provided.
|
|
| domain | founded_year | HQ Location |
Strategic consulting services are provided to life sciences companies.
|
Frequently Asked Questions about Fabtech
Fabtech was founded in 2002 and raised its 1st funding round 10 years after it was founded.
Fabtech is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Fabtech is a funded company, having raised a total of $175.05K across 1 funding round to date. The company's 1st funding round was a Seed of $175.05K, raised on Feb 28, 2012.
Annual revenue of Fabtech is $37.69M as on Mar 31, 2025.
Turnkey engineering solutions for pharmaceutical, biotech, and healthcare companies are delivered by Fabtech. Operations span across 62 countries, serving over 1300 customers. Solutions include start-to-finish engineering, air quality systems, water treatment, and process optimization. The mission to make medicines affordable and accessible is pursued by building pharmaceutical capabilities globally. Partnerships with bio-pharma companies in regions like West Africa, Latin America, and North Africa are established to enhance indigenous drug manufacturing.
Fabtech's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Fabtech offers Start-to-Finish Solutions, Solutions for Air, Solutions for Water, and Solutions for Process.
Yes, Fabtech is publicly traded on NSE under the ticker symbol FABTECH.
Fabtech has 1 investor. Key investors include Acaciaa International TR LLC.
The ticker symbol of Fabtech is FABTECH on NSE.
The valuation of Fabtech is $30.98M as of Feb 2012.